{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:18:14Z","timestamp":1773281894083,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2007,4,13]],"date-time":"2007-04-13T00:00:00Z","timestamp":1176422400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2007,9,24]]},"DOI":"10.1007\/s00417-007-0577-6","type":"journal-article","created":{"date-parts":[[2007,4,18]],"date-time":"2007-04-18T07:34:46Z","timestamp":1176881686000},"page":"1617-1621","source":"Crossref","is-referenced-by-count":12,"title":["Intraocular surgery under systemic interferon-alpha therapy in ocular Adamantiades-Beh\u00e7et\u2019s disease"],"prefix":"10.1007","volume":"245","author":[{"given":"Lothar","family":"Krause","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Altenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos E.","family":"Bechrakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregor","family":"Willerding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos C.","family":"Zouboulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael H.","family":"Foerster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,4,13]]},"reference":[{"key":"577_CR1","first-page":"271","volume":"168","author":"B Adamantiades","year":"1931","unstructured":"Adamantiades B (1931) Sur un cas d\u2019iritis \u00e0 hypopyon recidivant. Ann Oculist 168:271\u2013278","journal-title":"Ann Oculist"},{"key":"577_CR2","first-page":"1152","volume":"105","author":"H Beh\u00e7et","year":"1937","unstructured":"Beh\u00e7et H (1937) \u00dcber rezidivierende, apht\u00f6se, durch ein Virus verursachte Geschw\u00fcre im Mund, am Auge und an den Genitalien. Dermatol Wochenschr 105:1152\u20131157","journal-title":"Dermatol Wochenschr"},{"key":"577_CR3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF02912462","volume":"27","author":"R Rizzi","year":"1997","unstructured":"Rizzi R, Bruno S, Dammacco R (1997) Behcet\u2019s disease: an immune-mediated vasculitis involving vessels of all sizes. Int J Clin Lab Res 27:225\u2013232","journal-title":"Int J Clin Lab Res"},{"key":"577_CR4","doi-asserted-by":"crossref","first-page":"796","DOI":"10.2165\/00003495-199142050-00006","volume":"42","author":"H Yazici","year":"1991","unstructured":"Yazici H, Barnes CG (1991) Practical treatment recommendations for pharmacotherapy of Behcet\u2019s syndrome. Drugs 42:796\u2013804","journal-title":"Drugs"},{"key":"577_CR5","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1001\/archderm.134.8.1010","volume":"134","author":"CC Zouboulis","year":"1998","unstructured":"Zouboulis CC, Orfanos CE (1998) Treatment of Adamantiades-Behcet disease with systemic interferon alfa. Arch Dermatol 134:1010\u20131016","journal-title":"Arch Dermatol"},{"key":"577_CR6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00347-004-1166-2","volume":"102","author":"L Krause","year":"2005","unstructured":"Krause L (2005) [Adamantiades-Behcet\u2019s disease]. Ophthalmologe 102:329\u2013334","journal-title":"Ophthalmologe"},{"key":"577_CR7","first-page":"488","volume":"150","author":"CC Zouboulis","year":"1999","unstructured":"Zouboulis CC (1999) Epidemiology of Adamantiades-Behcet\u2019s disease. Ann Med Interne (Paris) 150:488\u2013498","journal-title":"Ann Med Interne (Paris)"},{"key":"577_CR8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ajo.2004.03.022","volume":"138","author":"I Tugal-Tutkun","year":"2004","unstructured":"Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Huseyin Altunbas H, Urgancioglu M (2004) Uveitis in Behcet disease: an analysis of 880 patients. Am J Ophthalmol 138:373\u2013380","journal-title":"Am J Ophthalmol"},{"key":"577_CR9","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3349\/ymj.1997.38.6.401","volume":"38","author":"D Bang","year":"1997","unstructured":"Bang D (1997) Treatment of Behcet\u2019s disease. Yonsei Med J 38:401\u2013410","journal-title":"Yonsei Med J"},{"key":"577_CR10","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/art.1780400425","volume":"40","author":"V Hamuryudan","year":"1997","unstructured":"Hamuryudan V, Ozyazgan Y, Hizli N, Mat C, Yurdakul S et al (1997) Azathioprine in Behcet\u2019s syndrome: effects on long-term prognosis. Arthritis Rheum 40:769\u2013774","journal-title":"Arthritis Rheum"},{"key":"577_CR11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJM199002013220501","volume":"322","author":"H Yazici","year":"1990","unstructured":"Yazici H, Pazarli H, Barnes CG, Tuzun Y, Ozyazgan Y et al (1990) A controlled trial of azathioprine in Behcet\u2019s syndrome. N Engl J Med 322:281\u2013285","journal-title":"N Engl J Med"},{"key":"577_CR12","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archderm.138.4.467","volume":"138","author":"E Alpsoy","year":"2002","unstructured":"Alpsoy E, Durusoy C, Yilmaz E, Ozgurel Y, Ermis O et al (2002) Interferon alfa-2a in the treatment of Behcet disease: a randomized placebo-controlled and double-blind study. Arch Dermatol 138:467\u2013471","journal-title":"Arch Dermatol"},{"key":"577_CR13","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/bjo.87.4.423","volume":"87","author":"I Kotter","year":"2003","unstructured":"Kotter I, Zierhut M, Eckstein AK, Vonthein R, Ness T et al (2003) Human recombinant interferon alfa-2a for the treatment of Behcet\u2019s disease with sight threatening posterior or panuveitis. Br J Ophthalmol 87:423\u2013431","journal-title":"Br J Ophthalmol"},{"key":"577_CR14","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/bjo.82.5.488","volume":"82","author":"I Kotter","year":"1998","unstructured":"Kotter I, Eckstein AK, Stubiger N, Zierhut M (1998) Treatment of ocular symptoms of Behcet\u2019s disease with interferon alpha 2a: a pilot study. Br J Ophthalmol 82:488\u2013494","journal-title":"Br J Ophthalmol"},{"key":"577_CR15","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/0-306-48382-3_103","volume":"528","author":"L Krause","year":"2003","unstructured":"Krause L, Turnbull JR, Torun N, Pleyer U, Zouboulis CC, Foerster MH (2003) Interferon alfa-2a in the treatment of ocular Adamantiades-Behcet\u2019s disease. Adv Exp Med Biol 528:511\u2013519","journal-title":"Adv Exp Med Biol"},{"issue":"12","key":"577_CR16","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1007\/s00417-006-0346-y","volume":"244","author":"I Tugal-Tutkun","year":"2006","unstructured":"Tugal-Tutkun I, Guney-Tefekli E, Urgancioglu M (2006) Results of interferon-alfa therapy in patients with Behcet uveitis. Graefes Arch Clin Exp Ophthalmol 244(12):1692\u20131695","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"577_CR17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1076\/ocii.8.4.293.6453","volume":"8","author":"B Wechsler","year":"2000","unstructured":"Wechsler B, Bodaghi B, Huong DL, Fardeau C, Amoura Z et al (2000) Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Behcet\u2019s disease. Ocul Immunol Inflamm 8:293\u2013301","journal-title":"Ocul Immunol Inflamm"},{"key":"577_CR18","first-page":"35","volume":"20","author":"O Ozdemir","year":"1988","unstructured":"Ozdemir O, Erkam N, Bakkaloglu A (1988) Results of pars plana vitrectomy in Behcet\u2019s disease. Ann Ophthalmol 20:35\u201338","journal-title":"Ann Ophthalmol"},{"key":"577_CR19","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1034\/j.1600-0420.2001.079002192.x","volume":"79","author":"Y Ozerturk","year":"2001","unstructured":"Ozerturk Y, Bardak Y, Durmus M (2001) Vitreoretinal surgery in Behcet\u2019s disease with severe ocular complications. Acta Ophthalmol Scand 79:192\u2013196","journal-title":"Acta Ophthalmol Scand"},{"key":"577_CR20","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s00417-003-0754-1","volume":"241","author":"L Krause","year":"2003","unstructured":"Krause L, Hoffmann F, Zouboulis CC, Foerster MH (2003) Vitrectomy and trabeculectomy combined with interferon alpha treatment in Adamantiades-Behcet\u2019s disease: a case report. Graefes Arch Clin Exp Ophthalmol 241:871\u2013874","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"577_CR21","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1034\/j.1600-0420.2000.078006680.x","volume":"78","author":"Y Sullu","year":"2000","unstructured":"Sullu Y, Oge I, Erkan D (2000) The results of cataract extraction and intraocular lens implantation in patients with Behcet\u2019s disease. Acta Ophthalmol Scand 78:680\u2013683","journal-title":"Acta Ophthalmol Scand"},{"key":"577_CR22","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0886-3350(01)01023-9","volume":"28","author":"S Kadayifcilar","year":"2002","unstructured":"Kadayifcilar S, Gedik S, Eldem B, Irkec M (2002) Cataract surgery in patients with Behcet\u2019s disease. J Cataract Refract Surg 28:316\u2013320","journal-title":"J Cataract Refract Surg"},{"key":"577_CR23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000050854","volume":"215","author":"T Matsuo","year":"2001","unstructured":"Matsuo T, Takahashi M, Inoue Y, Egi K, Kuwata Y, Yamaoka A (2001) Ocular attacks after phacoemulsification and intraocular lens implantation in patients with Behcet disease. Ophthalmologica 215:179\u2013182","journal-title":"Ophthalmologica"},{"key":"577_CR24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3928\/1542-8877-20040501-08","volume":"35","author":"N Berker","year":"2004","unstructured":"Berker N, Soykan E, Elgin U, Ozkan SS (2004) Phacoemulsification cataract extraction and intraocular lens implantation in patients with Behcet\u2019s disease. Ophthalmic Surg Lasers Imaging 35:215\u2013218","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"577_CR25","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/01.ijg.0000146624.31345.33","volume":"13","author":"IS Yalvac","year":"2004","unstructured":"Yalvac IS, Sungur G, Turhan E, Eksioglu U, Duman S (2004) Trabeculectomy with mitomycin-C in uveitic glaucoma associated with Behcet disease. J Glaucoma 13:450\u2013453","journal-title":"J Glaucoma"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-007-0577-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-007-0577-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-007-0577-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T15:40:32Z","timestamp":1559058032000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-007-0577-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,13]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,9,24]]}},"alternative-id":["577"],"URL":"https:\/\/doi.org\/10.1007\/s00417-007-0577-6","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,13]]}}}